Feb 19, 2025Journal ArticleDeep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.Written by 1 Roon author & 13 others Via Hepatology Communications
ResearchSustained Organ Preservation in Patients With Rectal Cancer After Sequential Short-Course Radiation Therapy and Chemotherapy.
ResearchNivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.
ResearchME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1.
ResearchSpatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia.
ResearchTumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma.
ResearchFinal Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.
ResearchSafety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.
ResearchA phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
ResearchSurgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer.
ResearchEvaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
ResearchCOMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.